Skip to main content

Table 3 Multivariate proportional hazard ratio for lung cancer death by gender

From: Important prognostic factors for the long-term survival of lung cancer subjects in Taiwan

Characteristics

Lung cancer death (N = 17,229)

 

Males

Females

 

HR (95% CI)

HR (95% CI)

Period of diagnosis (years)

  

   1987–1990

1.00 -

1.00 -

   1991–1994

1.13 (1.09–1.18)*

1.03 (0.97–1.10)

Diagnostic age (years)

  

   <= 39

1.00 -

1.00 -

   40–49

1.07 (0.93–1.25)

1.17 (1.00–1.37)

   50–59

1.25 (1.10–1.42)*

1.24 (1.07–1.43)*

   60–69

1.31 (1.15–1.48)*

1.30 (1.13–1.50)*

   >= 70

1.43 (1.26–1.62)*

1.37 (1.19–1.58)*

Resident area

  

   Hokkien community

1.00 -

1.00 -

   Aboriginal community

0.85 (0.75–0.96)*

1.13 (0.92–1.40)

   Hakka community

1.00 (0.94–1.07)

1.02 (0.91–1.14)

Histological type

  

   SQCC

1.00 -

1.00 -

   Adenocarcinoma

1.16 (1.11–1.21)*

1.06 (0.98–1.16)

   SCC

1.25 (1.17–1.33)*

1.07 (0.91–1.25)

   LCC

1.38 (1.21–1.57)*

1.24 (0.98–1.56)

   Carcinoma, NOS

1.16 (1.09–1.24)*

1.02 (0.90–1.15)

   Other carcinoma

0.78 (0.73–0.82)*

0.66 (0.60–0.73)*

Treatment modality

  

   CT

1.00 -

1.00 -

   Surgery resection

0.60 (0.56–0.65)*

0.49 (0.43–0.56)*

   RT

1.11 (1.04–1.19)*

1.07 (0.95–1.20)

   ST

1.17 (1.10–1.26)*

1.10 (0.98–1.23)

   Other complex therapy

1.43 (1.00–2.05)

1.20 (0.75–1.93)

   Unknown therapy

1.11 (1.04–1.18)*

1.02 (0.92–1.14)

  1. SQCC: squamous cell carcinoma; SCC: small cell carcinoma; LCC: large cell carcinoma. NOS: not otherwise specified. RT: radiation therapy; CT: chemotherapy; ST: supportive care therapy. HR: hazard ratio; CI: confidence interval. * Statistical significance (p < 0.05).
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us